Akanda (AKAN) vs Biote (BTMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Biote is the larger company by market cap ($26.3 million vs $11.2 million), about 2.4 times the size, while Akanda is growing revenue faster (+97.5% vs -2.5%). Biote converts more of its revenue into profit, with a net margin of 14.1% versus -489.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AKAN | BTMD |
|---|---|---|
| Share price | $4.23 | $0.8147 |
| Market cap | $11.16M | $26.28M |
| 1-day change | +23.32% | -3.56% |
| YTD return | — | -68.67% |
| 1-year return | — | -68.90% |
| 5-year return | — | -91.64% |
| Forward P/E | — | 3.33 |
| EPS (TTM) | $-14,935.32 | $-0.07 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $836.66K | $192.22M |
| Revenue growth (YoY) | +97.47% | -2.52% |
| Net income (latest FY) | $-4.10M | $27.05M |
| Gross margin | 24.91% | 71.46% |
| Operating margin | -523.80% | 18.50% |
| Net margin | -489.57% | 14.07% |
| 52-week high | $78.90 | $2.90 |
| 52-week low | $0.643 | $0.81 |
| Distance from 52-week high | -94.64% | -71.91% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +220.36% |
| Average volume | 6.86M | 146.21K |
| Shares outstanding | 2.39M | 27.04M |
| Employees | — | 223 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Medicinal Chemicals and Botanical Products |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Biote is about 2.4 times larger than Akanda by market value ($26.28M vs $11.16M).
- Biote is more profitable, keeping 14.1 cents of every revenue dollar as net income versus -489.6 cents for Akanda.
- Akanda grew revenue faster in its latest fiscal year (+97.47% vs -2.52%).
About Akanda
AKAN stock →Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers.
Health Care · Medicinal Chemicals and Botanical Products
About Biote
BTMD stock →biote Corp. operates in practice-building business within the hormone optimization space.
Health Care · Medicinal Chemicals and Botanical Products · 223 employees
AKAN vs BTMD FAQ
Which is bigger, Akanda or Biote?
Biote (BTMD) is larger, with a market capitalization of $26.28M compared with $11.16M for Akanda (AKAN).
Are Akanda and Biote in the same industry?
Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.